Learn how NIVH treatment can significantly reduce hospitalization and mortality in COPD and CRF patients.

Chronic Obstructive Pulmonary Disease (COPD) and Chronic Respiratory Failure (CRF) pose significant challenges to keeping patients healthy and out of the hospital. Peer-reviewed studies consistently show that NIVH treatment can reduce hospitalization and mortality, giving your patients a higher quality of life. 

Gain instant access to:

  • The webinar replay from Dr. William D. Frazier, board-certified Pulmonologist and Chief Medical Officer, who walks you through the latest developments in NIVH treatment.
  • Acquire insights into the proven clinical results of NIVH treatment and what it means for COPD and CRF patients.
  • Discover how NIV treatments can reduce patient mortality by 42% after only six months.
  • Learn how NIVH treatments can reduce costs and hospitalizations, save lives and money, and improve overall outcomes.

Complete the form below and have private access to these valuable resources instantly emailed to you.

Request Access to Research form